Background illustration for clinical trials search

Incyte Clinical Trials

Find clinical trials for Incyte. Search for Incyte clinical trials in different cities and states across the United States.

Filter
Active & Responsive

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult Participants

for
Healthy Participants
Location: Tempe AZ
Sponsor: Incyte Corporation

Sex: All

Age: 18 - 55

Code: NCT07448155

Phase1, Recruiting

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Boston MA, New York NY, Baltimore MD, Miami FL,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06034002

Phase1, Recruiting

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Montreal, Winston-Salem NC, Pittsburgh PA, Charlotte NC,
Sponsor: Incyte Corporation

Sex: Female

Age: 18+

Code: NCT07214779

Phase3, Recruiting

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

for
Solid Tumors, Hematologic Malignancies
Location: New York NY, Ann Arbor MI, Nashville TN, Omaha NE,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07195916

Phase1, Recruiting

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors
Location: Boston MA, Providence RI, Mineola NY, New York NY,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05836324

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

for
Graft-versus-host Disease (GVHD)
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06615050

Phase3, Recruiting

Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population

for
Pregnancy Related, Atopic Dermatitis
Location: Morrisville NC
Sponsor: Incyte Corporation

Sex: Female

Age: 15 - 50

Code: NCT06259669

Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: Halifax, Boston MA, Stony Brook NY, Hackensack NJ,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase3, Recruiting

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

for
Pregnancy Related, Atopic Dermatitis
Location: Morrisville NC
Sponsor: Incyte Corporation

Sex: Female

Age: 14+

Code: NCT06627335

Recruiting

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

for
Solid Tumors
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06179160

Phase1, Recruiting

To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva

for
Fibrodysplasia Ossificans Progressiva (FOP)
Location: Philadelphia PA, Rochester MN
Sponsor: Incyte Corporation

Sex: All

Age: 2 - 70+

Code: NCT05090891

Phase2, Recruiting

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Columbus OH, Atlanta GA, Nashville TN
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07441694

Phase1, Recruiting

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease

for
Renal Impairment
Location: Miami Lakes FL, Orlando FL
Sponsor: Incyte Corporation

Sex: All

Age: 18 - 70+

Code: NCT07559396

Phase1, Recruiting

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

for
Hepatic Insufficiency, Liver Diseases
Location: Orlando FL, San Antonio TX, Chandler AZ
Sponsor: Incyte Corporation

Sex: All

Age: 18 - 70+

Code: NCT07559474

Phase1, Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

for
Solid Tumors
Location: Boston MA, Lake Success NY, The Bronx NY, New York NY,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07522073

Phase3, Recruiting

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa (HS)
Location: St. John's, Boston MA, Farmington CT, Baltimore MD,
Sponsor: Incyte Corporation

Sex: All

Age: 12 - 17

Code: NCT07213973

Phase2, Recruiting

A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

for
Chronic Graft-versus-host-disease
Location: New York NY, Washington D.C. DC, Charlotte NC,
Sponsor: Incyte Corporation

Sex: All

Age: 2 - 17

Code: NCT07124078

Phase2, Recruiting

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

for
Immune Thrombocytopenia
Location: Boston MA, New Haven CT, The Bronx NY, Fairfax VA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07104565

Phase2, Recruiting

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: New York NY, Baltimore MD, Chapel Hill NC,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07008118

Phase1, Recruiting

A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

for
Essential Thrombocythemia
Location: Greenbrae CA
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07623200

Phase3, Recruiting